TABLE 4.
Summary of the linear mixed effect models with baseline continuous amyloid beta × time interaction on the BHA‐CS and the MoCA in CN (N = 119)
| BHA‐CS | MoCA | |||||
|---|---|---|---|---|---|---|
| B | SE | P value | B | SE | P value | |
| Intercept | 0.300 | 1.244 | .810 | 25.906 | 1.683 | <.001 |
| Baseline age | −0.007 | 0.013 | .601 | −0.082 | 0.026 | .002 |
| Female sex | 0.154 | 0.158 | .332 | 0.257 | 0.317 | .418 |
| APOE ε4 | 0.127 | 0.195 | .514 | 0.537 | 0.390 | .171 |
| Aβ SUVR | 0.452 | 0.739 | .542 | 0.852 | 1.585 | .592 |
| Time | 1.099 | 0.234 | <.001 | 0.380 | 0.669 | .571 |
| Aβ SUVR × time | −0.957 | 0.221 | <.001 | −0.303 | 0.628 | 630 |
Abbreviations: APOE, apolipoprotein E; Aβ, amyloid beta; B, unstandardized regression estimate; BHA‐CS, Brain Health Assessment‐Cognitive Score; CN, cognitively normal; MoCA, Montreal Cognitive Assessment; SE, standard error; SUVR, standardized uptake value ratio.